| Secondary |
| Epilepsy |
50.0% |
| Drug Use For Unknown Indication |
7.1% |
| Convulsion |
5.5% |
| Lennox-gastaut Syndrome |
5.0% |
| Insomnia |
4.6% |
| Product Used For Unknown Indication |
4.2% |
| Status Epilepticus |
4.2% |
| Liver Disorder |
3.4% |
| Hypertension |
2.5% |
| Diabetes Mellitus |
1.7% |
| Gastritis |
1.7% |
| Akathisia |
1.3% |
| Delusion |
1.3% |
| Hallucination |
1.3% |
| Myasthenia Gravis |
1.3% |
| Myoclonic Epilepsy |
1.3% |
| Tendonitis |
1.3% |
| Anxiety |
0.8% |
| Constipation |
0.8% |
| Diffuse Panbronchiolitis |
0.8% |
|
| Status Epilepticus |
8.3% |
| Stevens-johnson Syndrome |
8.3% |
| Surfactant Protein Increased |
8.3% |
| Foetal Exposure During Pregnancy |
5.6% |
| Renal Tubular Acidosis |
5.6% |
| Rhabdomyolysis |
5.6% |
| Somnolence |
5.6% |
| Speech Disorder |
5.6% |
| Suicide Attempt |
5.6% |
| Toxic Epidermal Necrolysis |
5.6% |
| Tri-iodothyronine Decreased |
5.6% |
| Urine Output Decreased |
5.6% |
| White Blood Cell Count Increased |
5.6% |
| Apnoea |
2.8% |
| Blood Urea Increased |
2.8% |
| Erythema Multiforme |
2.8% |
| Hallucination, Visual |
2.8% |
| High Density Lipoprotein Increased |
2.8% |
| Myasthenia Gravis |
2.8% |
| Oral Discomfort |
2.8% |
|
| Concomitant |
| Epilepsy |
42.4% |
| Drug Use For Unknown Indication |
24.1% |
| Complex Partial Seizures |
4.0% |
| Partial Seizures |
3.3% |
| Product Used For Unknown Indication |
3.1% |
| Convulsion |
3.0% |
| Myoclonic Epilepsy |
2.3% |
| Simple Partial Seizures |
2.3% |
| Grand Mal Convulsion |
2.0% |
| Lennox-gastaut Syndrome |
1.7% |
| Partial Seizures With Secondary Generalisation |
1.7% |
| Asthma |
1.7% |
| Prophylaxis |
1.6% |
| Anaplastic Astrocytoma |
1.3% |
| Hodgkin's Disease Nodular Sclerosis Stage Unspecified |
1.1% |
| Insomnia |
1.0% |
| Glioblastoma Multiforme |
0.9% |
| Pneumonia |
0.9% |
| Upper Respiratory Tract Inflammation |
0.8% |
| Intractable Epilepsy |
0.7% |
|
| Status Epilepticus |
14.1% |
| White Blood Cell Count Increased |
9.8% |
| Epilepsy |
8.6% |
| Pneumonia Aspiration |
5.5% |
| Somnolence |
5.5% |
| Thrombocytopenia |
5.5% |
| Pyrexia |
4.9% |
| Stevens-johnson Syndrome |
4.9% |
| Urinary Sediment Abnormal |
4.9% |
| Convulsion |
4.3% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.3% |
| Vomiting |
3.7% |
| Weight Increased |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| Attention Deficit/hyperactivity Disorder |
3.1% |
| Hyperamylasaemia |
3.1% |
| Hypoglycaemia |
3.1% |
| Blood Creatine Phosphokinase Increased |
2.5% |
| Calculus Urinary |
2.5% |
| Dystonia |
2.5% |
|
| Interacting |
| Tendonitis |
75.0% |
| Bacterial Disease Carrier |
25.0% |
|
|
